C-MER Eye Care Holdings Past Earnings Performance
Past criteria checks 2/6
C-MER Eye Care Holdings's earnings have been declining at an average annual rate of -23.6%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been growing at an average rate of 31.8% per year. C-MER Eye Care Holdings's return on equity is 4.3%, and it has net margins of 3.2%.
Key information
-23.6%
Earnings growth rate
-28.0%
EPS growth rate
Healthcare Industry Growth | 11.3% |
Revenue growth rate | 31.8% |
Return on equity | 4.3% |
Net Margin | 3.2% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point
Apr 29C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk
Feb 02C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively
Jan 17A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)
Apr 24Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal
Dec 04Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?
Sep 22Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year
Dec 07Revenue & Expenses BreakdownBeta
How C-MER Eye Care Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 1,924 | 62 | 503 | 0 |
30 Sep 23 | 1,862 | 28 | 505 | 0 |
30 Jun 23 | 1,801 | -7 | 506 | 0 |
31 Mar 23 | 1,766 | -14 | 489 | 0 |
31 Dec 22 | 1,732 | -22 | 472 | 0 |
30 Sep 22 | 1,602 | 1 | 445 | 0 |
30 Jun 22 | 1,473 | 23 | 418 | 0 |
31 Mar 22 | 1,293 | 22 | 389 | 0 |
31 Dec 21 | 1,113 | 22 | 361 | 0 |
30 Sep 21 | 1,036 | 25 | 325 | 0 |
30 Jun 21 | 959 | 28 | 289 | 0 |
31 Mar 21 | 829 | 11 | 249 | 0 |
31 Dec 20 | 700 | -6 | 209 | 0 |
30 Sep 20 | 636 | -10 | 185 | 0 |
30 Jun 20 | 573 | -13 | 161 | 0 |
31 Mar 20 | 575 | 14 | 153 | 0 |
31 Dec 19 | 576 | 41 | 145 | 0 |
30 Sep 19 | 539 | 53 | 129 | 0 |
30 Jun 19 | 502 | 64 | 114 | 0 |
31 Mar 19 | 466 | 53 | 103 | 0 |
31 Dec 18 | 429 | 43 | 91 | 0 |
30 Sep 18 | 396 | 35 | 81 | 0 |
30 Jun 18 | 363 | 27 | 71 | 0 |
31 Mar 18 | 341 | 31 | 64 | 0 |
31 Dec 17 | 311 | 40 | 55 | 0 |
30 Sep 17 | 293 | 46 | 48 | 0 |
30 Jun 17 | 274 | 52 | 42 | 0 |
31 Mar 17 | 267 | 55 | 41 | 0 |
31 Dec 16 | 249 | 47 | 38 | 0 |
31 Dec 15 | 199 | 38 | 31 | 0 |
31 Dec 14 | 156 | 22 | 31 | 0 |
Quality Earnings: 3309 has high quality earnings.
Growing Profit Margin: 3309 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3309's earnings have declined by 23.6% per year over the past 5 years.
Accelerating Growth: 3309 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 3309 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (2.2%).
Return on Equity
High ROE: 3309's Return on Equity (4.3%) is considered low.